Oscar Health closed at $35.19 on Nov 4, up 8.58% — matching its 52-week closing high. Volume of 13.5M shares was 2.93× its 20-day average (well above normal).
Split-adjusted performance: +8.8% over one month, +77.4% over six months, +99.3% over one year.
In the quarter ended Jun 30, 2026, revenue was $4.88B, up 70.4% from a year earlier, with a net margin of 7.4%.
Short interest was 18.3M shares at the Oct 15 settlement, up 11.2% from the prior report (7.2% of float, 3.7 days to cover).